跳至主要内容
临床试验/NCT00607880
NCT00607880已完成2 期

A Prospective Randomized Study of the Vortex® Implantable Access Port Versus the BardPort™ Implantable Port in Cancer Patients Receiving Adjuvant Intravenous Chemotherapy

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2004年6月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
Mayo Clinic
入组人数
100
试验地点
2
主要终点
Port Failure Within 12 Months of Port Insertion

研究概览

简要总结

RATIONALE: Giving chemotherapy drugs through an implanted port reduces the need for multiple needle sticks. It is not yet known whether one type of port is more effective than another in reducing infections and other side effects associated with long-term port use.

PURPOSE: This randomized clinical trial is comparing two types of ports in patients with cancer receiving intravenous chemotherapy.

详细描述

OBJECTIVES:

Primary

  • To compare the rate of port failure, defined as the occurrence of port malfunction or port infection within 12 months after port insertion, in patients with cancer requiring long-term adjuvant intravenous chemotherapy undergoing insertion of a newly designed, FDA-approved Vortex® implantable vascular access port vs a conventional vascular access port.

Secondary

  • To compare the rate of port malfunction or port infection at 6 and 12 months after port insertion.
  • To compare the rate of central vein thrombosis at 6 and 12 months after port insertion.
  • To compare the rate of port removal for any reason other than infection or occlusion at 6 and 12 months after port insertion.
  • To compare the rate of termination of use of the indwelling port at 6 and 12 months after port insertion.
  • To compare the death from all causes.
  • To compare the incidence of port-related interventions at 6 and 12 months after port insertion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Port Failure Within 12 Months of Port Insertion

时间窗: Up to 12 months from port insertion

We report the proportion of patients in each treatment group who have some degree of port failure. Port failure is defined as the composite outcome of port malfunction due to partial or total occlusion and any infection related to the port, within 12 months of port insertion. The percentages reported here are the number of patients that had reported a port failure within 12 months out of the number of patients with port failure within 12 months plus the number of patients that were followed 12 months without port failure.

次要结局

  • Death From All Causes(Up to 12 months after port insertion)
  • Port Removal for Any Reason Other Than Infection or Occlusion Within 12 Months After Port Insertion(Up to 12 months after port insertion)
  • Termination of Use of the Indwelling Port at 12 Months After Port Insertion(Up to 12 months after port insertion)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验